COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 131 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97 | -4.0% | 4,351 | -8.2% | 0.00% | – |
| Q2 2023 | $101 | -75.9% | 4,739 | -72.9% | 0.00% | – |
| Q1 2023 | $419 | -91.6% | 17,483 | +6949.6% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 248 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -87.8% | 248 | -85.9% | 0.00% | – |
| Q1 2021 | $41,000 | +485.7% | 1,759 | +326.9% | 0.00% | – |
| Q2 2020 | $7,000 | -80.6% | 412 | -77.0% | 0.00% | – |
| Q4 2019 | $36,000 | +350.0% | 1,793 | +156.5% | 0.00% | – |
| Q3 2019 | $8,000 | -73.3% | 699 | -70.3% | 0.00% | – |
| Q2 2019 | $30,000 | +900.0% | 2,353 | +901.3% | 0.00% | – |
| Q1 2019 | $3,000 | -78.6% | 235 | -60.3% | 0.00% | – |
| Q2 2018 | $14,000 | -60.0% | 592 | -57.6% | 0.00% | -100.0% |
| Q1 2018 | $35,000 | -47.0% | 1,397 | -61.3% | 0.00% | -33.3% |
| Q4 2017 | $66,000 | +3200.0% | 3,612 | +1305.4% | 0.00% | – |
| Q3 2017 | $2,000 | – | 257 | +559.0% | 0.00% | – |
| Q2 2017 | $0 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |